311 Followers on Owler

Vanda

Pharmaceuticals develops and commercializes pharmaceutical products for the treatment of central nervous system disorders... Read more
OverviewCompetitorsFundingNews & Insights

Vanda

Pharmaceuticals develops and commercializes pharmaceutical products for the treatment of central nervous system disorders... Read more
Vanda President & CEO: Mihael H. Polymeropoulos

President & CEO

Mihael H. Polymeropoulos

CEO Approval Rating

86/100

2003

PublicNASDAQVNDA

Pharmaceuticals & Biotechnology
Pharmaceuticals
28342836 NAICS listing

Annual Revenue
$198.8M
Employees
290
Funding
$353.3M

News

Regulatory
Jan 16, 2025
PharmaLive
After letter to commissioner, FDA fnally gives Vanda reason for rejection, chance for hearing

Vanda Competitors

1Oxford Immunotec
2Kite Pharma
3Immunocore
4Adaptimmune
5Merck
6Sanofi Pasteur
7Illumina
8Roche
9GSK
10Pfizer
Unlock 16 + competitors

Trending Companies